These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2628085)
1. Species differences in the hepatic response to a potent peroxisome proliferator. Makowska JM; Bonner FW; Goldfarb PS; Gibson GG Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085 [No Abstract] [Full Text] [Related]
2. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105 [TBL] [Abstract][Full Text] [Related]
3. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound. Rao MS; Dwivedi RS; Subbarao V; Reddy JK Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849 [TBL] [Abstract][Full Text] [Related]
4. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats. Rao MS; Subbarao V; Reddy JK Cancer Lett; 1986 Jul; 32(1):33-9. PubMed ID: 3742486 [TBL] [Abstract][Full Text] [Related]
5. Toxicological evaluation of peroxisome proliferators. Further cellular and molecular aspects. Passilly P; Pacot C; Jannin B; Cherkaoui Malki M; Bardot O; Caira F; Clemencet MC; Latruffe N Ann N Y Acad Sci; 1996 Dec; 804():716-8. PubMed ID: 8993603 [No Abstract] [Full Text] [Related]
6. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. Awasthi YC; Singh SV; Goel SK; Reddy JK Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318 [TBL] [Abstract][Full Text] [Related]
7. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Li Y; Leung LK; Glauert HP; Spear BT Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042 [TBL] [Abstract][Full Text] [Related]
8. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis. Glauert HP; Clark TD Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376 [TBL] [Abstract][Full Text] [Related]
9. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset. Makowska JM; Bonner FW; Gibson GG Arch Toxicol; 1991; 65(2):106-13. PubMed ID: 1905530 [TBL] [Abstract][Full Text] [Related]
10. Influence of a fibric acid type of hypolipidemic agent on the oxidative metabolism of arachidonic acid by liver microsomal cytochrome P-450. Capdevila J; Kim YR; Martin-Wixtrom C; Falck JR; Manna S; Estabrook RW Arch Biochem Biophys; 1985 Nov; 243(1):8-19. PubMed ID: 3933431 [TBL] [Abstract][Full Text] [Related]
11. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes. Cornu-Chagnon MC; Dupont H; Edgar A Fundam Appl Toxicol; 1995 Jun; 26(1):63-74. PubMed ID: 7657063 [TBL] [Abstract][Full Text] [Related]
12. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745 [TBL] [Abstract][Full Text] [Related]
13. The herbicide dicamba (2-methoxy-3,6-dichlorobenzoic acid) is a peroxisome proliferator in rats. Espandiari P; Thomas VA; Glauert HP; O'Brien M; Noonan D; Robertson LW Fundam Appl Toxicol; 1995 Jun; 26(1):85-90. PubMed ID: 7657066 [TBL] [Abstract][Full Text] [Related]
15. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents. Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901 [TBL] [Abstract][Full Text] [Related]
16. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate. Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129 [TBL] [Abstract][Full Text] [Related]
18. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator. Milano M; Reddy JK; Prasad JD; Rao MS Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-induced hepatocarcinogenesis: levels of activating and detoxifying enzymes in hepatocellular carcinomas induced by ciprofibrate. Rao MS; Kokkinakis DM; Subbarao V; Reddy JK Carcinogenesis; 1987 Jan; 8(1):19-23. PubMed ID: 3100085 [TBL] [Abstract][Full Text] [Related]
20. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator. Rao MS; Subbarao V Cancer Lett; 1995 Nov; 97(2):185-8. PubMed ID: 7497461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]